FDMT SEC Filings - 4D Molecular Therapeutics Inc. 10-K, 10-Q, 8-K Forms

2026-04-01 02:19:36

Abstract generation in progress

This page provides a comprehensive resource for 4D Molecular Therapeutics (FDMT) SEC filings, including annual reports, quarterly earnings, material events, and insider trading forms. It highlights recent Form 8-K filings detailing clinical trial data, collaborations, and executive appointments. The platform also offers AI-powered summaries and sentiment analysis for these regulatory documents.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.